-
Mashup Score: 8
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 109
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Please do read our letter to editor to @JCO_ASCO with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms? Congratulations @abhenilmittal for raising awareness re this important issue. https://t.co/UrHNIB20tF https://t.co/sqv1H0cQFc
-
-
Mashup Score: 103
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Please do read our letter to editor to @JCO_ASCO with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms? Congratulations @abhenilmittal for raising awareness re this important issue. https://t.co/UrHNIB20tF https://t.co/sqv1H0cQFc
-
-
Mashup Score: 7
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Here is the response to our letter by the study authors: https://t.co/W70yDdQVoz
-
-
Mashup Score: 103
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Please do read our letter to editor to @JCO_ASCO with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms? Congratulations @abhenilmittal for raising awareness re this important issue. https://t.co/UrHNIB20tF https://t.co/sqv1H0cQFc
-
-
Mashup Score: 2Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice - 5 day(s) ago
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from high-income countries, which may not apply to LMICs. The causes and consequences of …This new article provides a comprehensive overview of how cancer treatment-related FT is defined across LMICs.
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
However, if you look at studies on FT from LMICs, you’ll see that the definition is neither standardized nor tailored to the specific contexts. Everyone is defining FT whatever way they want. https://t.co/nfNskuLo8W
-
-
Mashup Score: 10Canadian Undergraduate Conference on Healthcare (CUCOH) - 6 day(s) ago
The Canadian Undergraduate Conference on Healthcare (CUCOH) is a two-day conference that enables undergraduate students to engage in hands-on workshops and discussions that showcase the multidisciplinary nature of healthcare.
Source: www.cucoh.comCategories: General Medicine News, Hem/OncsTweet-
For people in and around Kingston- specially the undergrads and med students- I have the pleasure of doing a keynote address at the 2025 CUCOH conference in @queensu this Saturday. Please join, if you’re interested. Details here- https://t.co/SZKXIrAwBM https://t.co/wjERZxFA0m
-
-
Mashup Score: 68ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update - 6 day(s) ago
The availability and affordability of safe, effective cancer therapies are core requirements for effective cancer control. Global disparities exist in access, however, yielding unequal cancer outcomes. The goal of this study was to provide updated data regarding the formulary availability, out-of-pocket costs, and accessibility of cancer medicines in countries across the full spectrum of economic development areas.
Source: www.annalsofoncology.orgCategories: General Medicine News, Hem/OncsTweet-
Published today in @Annals_Oncology , the results from our updated @myESMO Global consortium study on the availability, affordability, and accessibility of cancers medicines. https://t.co/znHhSa1r3a https://t.co/ZJpLNaeivc
-
-
Mashup Score: 4
Bishal Gyawali: Ever wondered how I read clinical trial reports? / Bishal Gyawali, cancer, clinical trial, OncoDaily, Oncology, Queen’s University, Skills Lab
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Ever wondered how I read clinical trial reports? - @oncology_bg https://t.co/FQHysCHvFW #Cancer #ClinicalTrial #MedX #MedN…
-
-
Mashup Score: 2Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice - 7 day(s) ago
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from high-income countries, which may not apply to LMICs. The causes and consequences of …This new article provides a comprehensive overview of how cancer treatment-related FT is defined across LMICs.
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
However, if you look at studies on FT from LMICs, you’ll see that the definition is neither standardized nor tailored to the specific contexts. Everyone is defining FT whatever way they want. https://t.co/nfNskuLo8W
-
Here is the response to our letter by the study authors: https://t.co/W70yDdQVoz